Is Cytotron FDA approved?

The FDA recognizes the Cytotron as a Breakthrough Device for the treatment of Breast, Pancreas and Liver Cancers, by conducting a clinical trial to establish that it is better than existing standards of care for these indications.

How does Cytotron work?

“Cytotron stops the cancer tissue from multiplying and spreading to other organs. Once the tumor stops growing or spreading, what we do at Cytotron is plant the flag (protein) down, which determines that the cell is old enough to die.

What is Cytotron device?

The Cytotron® is a stand-alone device based on Rotational Field Quantum Magnetic Resonance (RFQMR) platform technology which enables whole body therapeutics called Quantum Magnetic Resonance Therapy (QMRT).

Who developed Cytotron?

Cytotron, developed by Rajah Vijay Kumar, aids in tissue engineering of cancer cells, altering how specific proteins are regulated to stop these cells from multiplying and spreading.

Is Erleada a biologic?

Apalutamide is an antiandrogen, and acts as an antagonist of the androgen receptor, the biological target of androgens like testosterone and dihydrotestosterone….Apalutamide.

Clinical data
License data	US DailyMed: Erleada
Pregnancy category	AU : D
Routes of administration	By mouth
Drug class	Nonsteroidal antiandrogen

Is Erleada a hormone therapy?

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant).

What is Rotational Field Quantum Magnetic Resonance Therapy?

Generically known as Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR), it is a technology that is made to deliver highly complex quantum instantaneous Nuclear Magnetic Resonance beams in the RF bands and its harmonics ranging from 3KHz to 300 MHz with a near field delivery using specialized antenna in the …

What is Rfqmr?

Rotational Field Quantum Magnetic Resonance (RFQMR) is a technology that is made to deliver highly complex quantum electromagnetic beams in the sub-radio and near-radio frequency spectrum.

What type of drug is Erleada?

This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.

What are the side effects of Erleada?

ERLEADA® may cause serious side effects including:

• chest pain or discomfort at rest or with activity.
• shortness of breath.
• numbness or weakness of the face, arm, or leg, especially on one side of the body.
• trouble talking or understanding.
• trouble seeing in one or both eyes.

How long do patients take Erleada?

Erleada (apalutamide) is usually taken until cancer progresses past a certain point or you start to have unacceptable side effects. In the SPARTAN clinical trial (NCT01946204) using apalutamide for men with castration-resistant metastasis-free prostate cancer, some patients were still using apalutamide at 36 months.

When is the best time to take Erleada?

Take your prescribed dose of ERLEADA® 1 time a day, at the same time each day. Take ERLEADA® with or without food. Swallow ERLEADA® tablets whole. If you miss a dose of ERLEADA®, take your normal dose as soon as possible on the same day.

What is cytotron ® treatment?

Essentially, the Cytotron ® treatment helps to re-generate cells and/or to stop the uncontrolled growth of cells. Clinical experience shows that it is particularly effective for cancer and for arthritis. In conventional cancer treatment, chemo/radiation therapies physically destroy cancer cells to arrest tumour growth.

Can the cytotron be used to treat cancer and osteoarthritis?

With the Cytotron now being recognized and accepted as one of the therapeutic modality with the grant of the EU certification, there has been a widespread interest in the technology for the treatment of cancer and osteoarthritis.

What is the difference between cytotron and chemotherapy?

In fact, combining Cytotron with chemotherapy, substantially reduces the side-effects of even powerful chemotherapeutic molecules. On the other hand, Cytotron radiosensitize the tumor for traditional radiotherapy to work better on the tumor and reduce collateral damages as the surrounding tissue will have lower radiosensitivity.

What types of solid tumors can cytotron 864 treat?

Cytotron 864 can treat all types of solid tumors, including widely metastatic disease in terminal patients. Though terminal systemic malignant diseases can be treated, no trials have been conducted so far to prove its efficacy in patients.